GLP-1 Improves Adipocyte Insulin Sensitivity Following Induction of Endoplasmic Reticulum Stress
Overview
Affiliations
Glucagon-like peptide 1 (GLP-1) improves insulin resistance of adipose tissue in obese humans. However, the mechanism of this effect is unclear. Perturbation of endoplasmic reticulum (ER) homeostasis impairs insulin signaling. We hypothesized that GLP-1 could directly improve insulin signaling in ER-stressed adipocytes. Here, we examined the effects of GLP-1 on ER stress response in fat cells in an obese and insulin-resistant murine model. We found that GLP-1 analog liraglutide reduced ER stress related gene expression in visceral fat cells accompanied by improved systemic insulin tolerance. Consistently, GLP-1 decreased CHOP expression and increased insulin stimulated AKT phosphorylation (p-AKT) in thapsigargin, a ER stress inducer, treated white fat cells differentiated from visceral stromal vascular fraction. We further found blocking CHOP expression increased insulin stimulated p-AKT in ER-stressed fat cells. Of note, we found mTOR signaling pathway contributed to the expression of ATF4 and subsequently the CHOP expression in ER stress response, while GLP-1 inhibited mTOR activity as exemplified by elevated autophagosome formation and increased LC3II/LC3I ratio. These findings suggest that GLP-1 directly modulates the ER stress response partially via inhibiting mTOR signaling pathway, leading to increased insulin sensitivity in adipocytes.
Konings L, Miguelanez-Matute L, Boeren A, van de Luitgaarden I, Dirksmeier F, de Knegt R Eur J Clin Invest. 2025; 55(4):e70003.
PMID: 39937036 PMC: 11891831. DOI: 10.1111/eci.70003.
Metabolic Status Modulates Global and Local Brain Age Estimates in Overweight and Obese Adults.
Haas S, Abbasi F, Watson K, Robakis T, Myoraku A, Frangou S Biol Psychiatry Cogn Neurosci Neuroimaging. 2024; 10(3):278-285.
PMID: 39615789 PMC: 11890935. DOI: 10.1016/j.bpsc.2024.11.017.
Eldakhakhny B, Bima A, Alamoudi A, Alnami A, Abo-Elkhair S, Sakr H Front Nutr. 2024; 11:1467719.
PMID: 39610878 PMC: 11603365. DOI: 10.3389/fnut.2024.1467719.
Jiang Y, Guo J, Wu Y, Zheng P, Wang S, Yang M Ther Adv Endocrinol Metab. 2024; 15:20420188241282707.
PMID: 39381518 PMC: 11459521. DOI: 10.1177/20420188241282707.
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy.
Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C Signal Transduct Target Ther. 2024; 9(1):234.
PMID: 39289339 PMC: 11408715. DOI: 10.1038/s41392-024-01931-z.